TissuPath’s Research Programs, tissue banking, development, diagnosis - Melbourne Victoria Australia

Our Research Programs

TissuPath's Research Programs

TissuPath is unique among private pathology laboratories in that it has both an in-house research program as well as numerous collaborative programs with Australian universities, research institutes, foundations and biotechnology companies.

A partial list of TissuPath's current research programs:

Improved FISH methods for detecting 1p and 19q chromosome deletions in oligodendrogliomas

Download Gonzales et al
FISH oligodendroglioma paper
Influence of heterogeneity of chromosome deletions and EGF-receptor expression on outcome of chemotherapy in oligodendrogliomas (collaborator: Royal Melbourne Hospital)
Can DNET and oligodendroglioma with DNET morphology be differentiated using FISH for 1p and 19q chromosome deletions.

Download Gonzales et al
DNET paper

Expression of SRD5alphaR1 in prostate cancer (collaborator: Dalhousie University, Halifax, Nova Scotia)
Development and validation of immunohistochemical markers for prediction of outcomes following radical prostatectomy, and for predicting the need for surgery following needle biopsy (Collaborators: Cancer Council Victoria; Royal Melbourne Hospital; Alfred Hospital)
Correlation between MRI imaging of prostate cancer in vivo and actual tumour mass and localization following radical prostatectomy (Collaborator: Mercy Hospital Private Radiology, Melbourne)
Relationship between prostate cancer and stem cells (Collaborator: Monash Institute for Medical Research)
Role of inhibins in development of prostate cancer (Collaborator: Monash Institute for Medical Research)
Anatomy of the seminal vesicles (Collaborator: Royal Melbourne Hospital)
Using morphological and protein expression markers to subdivide prostate cancers of Gleason pattern 3 (Collaborator: Monash Institute for Medical Research)
Can expression of apoptosis markers assist in diagnosis of prostate cancer? (Collaborator: Peptech and Biosceptre Corporation, Sydney).
Assessment of specific antibodies as a diagnostic test for the presence of prostate cancer (Proteome Systems Limited).

TissuPath is actively involved in "tissue banking" (freezing leftover pathology specimens for use in future research, with approval of the patient) and is the only private pathology laboratory that is an Affiliate Member of the recently-funded Victorian Cancer BioBank as well as a Founding Member of the Victorian Prostate Cancer Research Consortium.